PhIII MultiCentreMulti-NationalControl Tria Inves1cmv2cm WideExcision Margins Primary Cutaneous MelaMaki YamamotoOPEN TO ACCRUALGet More Information
D6970C00002: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Participants Ekamol TantisattamoOPEN TO ACCRUALGet More Information
A Phase 2 Randomized, Double-blind, Placebo-controlled StudyFelice LinOPEN TO ACCRUALGet More Information
A Long-term Follow-up Study of Sotatercept for PAH Treatment Bassam YaghmourOPEN TO ACCRUALGet More Information
PhI/II Study of HM43239 in Patients with Relapsed or Refractory AMLDeepa JeyakumarOPEN TO ACCRUALGet More Information
PhIb/II IntravesInstillation of TARA-002 in Adults w/High-grade Non-muscle Invasive Bladder CancerEdward UchioOPEN TO ACCRUALGet More Information
PhIII TrialSingFractionStereotacticRadiosurgVSFractionatedSRS IntactBrainMetsAaron SimonOPEN TO ACCRUALGet More Information
Phase 1 Trial of Iadademstat in Combination with Venetoclax and AzacitidineKiran NaqviOPEN TO ACCRUALGet More Information
OpenLabe DoseEscal PhI/II StudyTAK-676 SingleAge&Comb w/Pembrolizumab inAdult Pa w/Adv orMetaSolidTuRupali NabarOPEN TO ACCRUALGet More Information
Metronomic Cyclophosphamide with Pembrolizumab in Checkpoint Inhibitor Refractory MelanomaWarren A ChowOPEN TO ACCRUALGet More Information
Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma GelsolinAlpesh AminOPEN TO ACCRUALGet More Information
A prospective, multicenter, single arm, open-label, feasibility study to evaluate the safetyPengbo JiangOPEN TO ACCRUALGet More Information
PhIb AMG 193 Alone or Comb w/OtherTherapies in Sbjcts w/AdvThoracicTumors w/Homozygous MTAPDeletionMiguel Villalona-CaleroOPEN TO ACCRUALGet More Information
ph3 Telitacicept In Patients With Generalized Myastenia GravisAli HabibOPEN TO ACCRUALGet More Information
FIH Study of IK-595 Oral Dual MEK/RAF Inhibitor in Pts W/ RAS- Or RAF- Altered Adv Solid TumorsJennifer Brooke ValerinOPEN TO ACCRUALGet More Information
ARC-311 for Patients with Non-Oncology Plasma Cell-Related DiseasesAli HabibOPEN TO ACCRUALGet More Information
A Phase 2, Open-Label, Multicentre Study of KYV-101 in Subjects with Refractory Generalized MyastheAli HabibOPEN TO ACCRUALGet More Information
study to validate a serum-based biomarkers panel to detect mucosal healing in moderate-to-severe UC Nimisha ParekhOPEN TO ACCRUALGet More Information
Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson DiseaseNicolas PhielippOPEN TO ACCRUALGet More Information